A U.S. Food and Drug Administration advisory committee has voted to recommend emergency use authorization for Pfizerâs coronavirus vaccine, marking a historic breakthrough amid some of the deadliest days of the pandemic.
âWe will take into consideration what we heard today when deciding on not only EUA issuance here but also how to move on in the development and licensure of this product,â said Marion Gruber, director of the office of vaccines research and review at the FDA.
âEUAâ means emergency use authorization. Thatâs different than FDA approval, which is expected to come later, but it does allow widespread use of the vaccine and continued monitoring.